Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program

Hematological Oncology

Volumn 28, Issue 3, 2010, Pages 133-136

  Abel, Gregory A ^a   Bertrand, Kimberly A ^b   Earle, Craig C ^c   Laden, Francine ^b,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Haematologic malignancy; Health services research; Leukaemia; Lymphoma; Myeloma

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; FEMALE; HEALTH PROGRAM; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NURSE; PRIORITY JOURNAL; CANCER REGISTRY; COHORT ANALYSIS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 77957325438     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.930     Document Type: Article

References (14)

1. Overview of the SEER Program. Available at: http://seer.cancer.gov/about/ [Accessed on 15 October 2008].
2. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107(1): 265-276.
3. Pulte D, Gondos A, Brenner H. Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 2008; 168(5): 469-476.
4. Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005; 23(22): 5019-5026.
5. Abel GA, Friese CR, Magazu LS, et al. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma 2008; 49(7): 1352-1359.
6. Seftel MD, Demers AA, Banerji V, et al. High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. Leuk Res 2009; 4: 4.
7. Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Canc Epidemiol Biomarkers Prev 2004; 13(1): 138-143. (Pubitemid 38116631)
8. Weinstock MA, Reynes JF. Validation of cause-of-death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides. Am J Epidemiol 1998; 148(12): 1184-1186.
9. Gatta G, Capocaccia R, Coleman MP, et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000; 89(4): 893-900. (Pubitemid 30658591)
10. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008; 112(1): 45-52.
11. Surveillance Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, November 2006 Sub (1973-2004) - Linked To County Attributes - Total U.S., 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
12. Surveillance Research Program. National Cancer Institute SEER*Stat software (www.seer.cancer.gov) version 6.3.6.
13. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
14. Descatha A, Jenabian A, Conso F, Ameille J. Occupational exposures and haematological malignancies: overview on human recent data. Canc Causes Contr 2005; 16(8): 939-953. (Pubitemid 41191419)